When is it safe to stop Pneumocystis jiroveci pneumonia prophylaxis? Insights from three cases complicating autoimmune diseases

Arthritis Care and Research

Volumn 59, Issue 7, 2008, Pages 1034-1039

  Suryaprasad, Anil ^a   Stone, John H ^b  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; AZATHIOPRINE; CLINDAMYCIN; COTRIMOXAZOLE; CYCLOSPORIN; DAPSONE; GLUCOCORTICOID; METHOTREXATE; METHYLPREDNISOLONE; PENTAMIDINE; PREDNISONE; PRIMAQUINE;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BLOOD DYSCRASIA; BONE MARROW SUPPRESSION; CASE REPORT; CHOLESTATIC HEPATITIS; DIARRHEA; DRUG COST; DRUG DOSE REDUCTION; DRUG FEVER; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYTIC ANEMIA; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPOGLYCEMIA; HYPOTENSION; IMMUNE COMPLEX NEPHRITIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEPHROTOXICITY; PHOTOSENSITIVITY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PROPHYLAXIS; PRURITUS; RASH; SERUM SICKNESS; SINGLE DRUG DOSE; STEVENS JOHNSON SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; WEGENER GRANULOMATOSIS;

ADULT; AGED; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIBIOTIC PROPHYLAXIS; AUTOIMMUNE DISEASES; CD4 LYMPHOCYTE COUNT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS;

EID: 47249104373     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23822     Document Type: Article

References (36)

1. Follansbee SE, Busch DF, Wofsy CB, Coleman DL, Gullet J, Aurigemma GP, et al. An outbreak of Pneumocystis carinii pneumonia in homosexual men. Ann Intern Med 1982;96:705-13.
2. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR Recomm Rep 1992;41:1-11.
3. Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Baird BF, Travis W, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 1989;111:223-31.
4. Ammann A. Summary and recommendations: cotrimoxazole prophylaxis for HIV-related infections in adults, infants, and children in resource-limited settings. 2002. URL: http://www.womenchildrenhiv.org/wchiv?page=ch-04-01.
5. Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 2007;82:1052-9.
6. Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev 2007;3:CD005590.
7. Rodriguez M, Fishman JA. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus: negative immunocompromised patients. Clin Microbiol Rev 2004;17:770-82.
8. Hughes WT. Five-year absence of Pneumocystis carinii pneumonitis in a pediatric oncology center. J Infect Dis 1984;150:305-6.
9. Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997;40:2187-98.
10. Li J, Huang XM, Fang WG, Zeng XJ. Pneumocystis carinii pneumonia in patients with connective tissue disease. J Clin Rheumatol 2006;12:114-7.
11. Sato T, Inokuma S, Maezawa R, Nakayama H, Hamasaki K, Miwa Y, et al. Clinical characteristics of Pneumocystis carinii pneumonia in patients with connective tissue diseases. Mod Rheumatol 2005;15:191-7.
12. Mansharamani NG, Garland R, Delaney D, Koziel H. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000;118:704-11.
13. Ward MM, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum 1999;42:780-9.
14. Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med 2004;350:2487-98.
15. Walzer PD, Smulian AG. Pneumocystis species. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 6th ed. Edinburgh: Elsevier Churchill Livingstone; 2004. p. 3080-94.
16. Churg J, Sobin LH. Lupus nephritis. In: Renal disease: classification and atlas of glomerular diseases. 1st ed. Tokyo: Igaku-Shoin; 1982. p. 127-49.
17. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited [published erratum appears in J Am Soc Nephrol 2004;15:835-6]. J Am Soc Nephrol 2004;15:241-50.
18. Austin HA III, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, et al. Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986;314:614-9.
19. Pope J, Jerome D, Fenlon D, Krizova A, Ouimet J. Frequency of adverse drug reactions in patients with systemic lupus erythematosus. J Rheumatol 2003;30:480-4.
20. Bachelez H, Schremmer B, Cadranel J, Mouly F, Sarfati C, Agbalika F, et al. Fulminant Pneumocystis carinii pneumonia in 4 patients with dermatomyositis. Arch Intern Med 1997;157:1501-3.
21. Kadoya A, Okada J, Iikuni Y, Kondo H. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus. J Rheumatol 1996;23:1186-8.
22. Viguier M, Fouere S, de la Salmoniere P, Rabian C, Lebbe C, Dubertret L, et al. Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy. Medicine (Baltimore) 2003;82:82-6.
23. Koldingsnes W, Gran JT, Omdal R, Husby G. Wegener's granulomatosis: long-term follow-up of patients treated with pulse cyclophosphamide. Br J Rheumatol 1998;37:659-64.
24. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
25. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006;354:2655-66.
26. Godeau B, Coutant-Perronne V, Le Thi Huong D, Guillevin L, Magadur G, De Bandt M, et al. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 1994;21:246-51.
27. Porges AJ, Beattie SL, Ritchlin C, Kimberly RP, Christian CL. Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia. J Rheumatol 1992;19:1191-4.
28. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 1996;71:5-13.
29. Sepkowitz KA. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: who should receive prophylaxis? Mayo Clin Proc 1996;71:102-3.
30. Sepkowitz KA, Brown AE, Armstrong D. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: more patients, same risk. Arch Intern Med 1995;155:1125-8.
31. Unwin B, Williams CM, Gilliland W. Polymyalgia rheumatica and giant cell arteritis. Am Fam Physician 2006;74:1547-54.
32. Grutters JC, van den Bosch JM. Corticosteroid treatment in sarcoidosis. Eur Respir J 2006;28:627-36.
33. Kaur N, Mahl TC. Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases. Dig Dis Sci 2007;52:1481-4.
34. Fauci AS, Dale DC, Wolff SM. Cyclophosphamide and lymphocyte subpopulations in Wegener's granulomatosis. Arthritis Rheum 1974;17:355-61.
35. Gordon SM, LaRosa SP, Kalmadi S, Arroliga AC, Avery RK, Truesdell-LaRosa L, et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis 1999;28:240-6.
36. Johns Hopkins University. The Johns Hopkins HIV guide: Pneumocystis carinii pneumonia. URL: http://www.hopkins-hivguide.org/diagnosis/ opportunistic_infections/fungal/pneumocystis_carinii_pneumonia.html? contentInstanceId=12191&siteId=7151.